Overview

This book comprehensively reviews the current state of clinical trial methods in multiple sclerosis treatment, providing investigators, sponsors and specialists with current knowledge of outcome measures and study designs for disease and symptom management.

Current Developments

The status of the rapidly evolving field of disease-modifying drugs is presented, with emphasis on the most promising therapies currently being tested.

Expert Discussions

Experts discuss disease and symptom management for MS subtypes, including neuromyelitis optica and pediatric MS.

Scientific Advances

In addition, key scientific advances in MS pathology, genetics, immunology and epidemiology are presented.

Edition Highlights

The fourth edition has been extensively revised, featuring more than 50% new material. All chapters have been substantially updated to provide current information on rapidly evolving topics and this volume contains 15 new chapters, reflecting the growth of the field in recent years.

Target Audience

This book is an essential reference for practitioners caring for MS patients, investigators planning or conducting clinical trials, and clinical trial sponsors.